Home » Healthcare » Drug Discovery Outsourcing Market

Drug Discovery Outsourcing Market By Preclinical Services (Biochemical Assays, In Vitro and In Vivo Pharmacology, Toxicology Studies); By Chemistry Services (Medicinal Chemistry, Analytical Chemistry); By Biology Services (Cell Biology, Molecular Biology); By Target Identification and Validation (Genomic Services, Proteomic Services); By Clinical Research Services (Clinical Trial Management, Clinical Monitoring); By Therapeutic Area (Oncology, Neurology, Infectious Diseases); By End-User (Pharmaceutical and Biotechnology Companies, Government and Academic Institutions, Research and Development Companies); By Technology Platforms (High-Throughput Screening, Structure-Based Drug Design); By Contract Models (Full-Service Outsourcing, Functional Service Outsourcing) – Global Industry Analysis, Trends, and Forecast, 2024 – 2032

Summary
Table Of Content

Market Insights

The global demand for drug discovery outsourcing was valued at USD 3748.5 Million in 2022 and is expected to reach USD 6938.2 Million in 2030, expanding at a CAGR of 8% between 2023 and 2030.
The biochemical assay segment is the market leader in preclinical services, accounting for more than 40% of the total value in 2022, while the toxicology studies category is estimated to grow rapidly in the projection period.
The molecular biology segment is expected to expand rapidly in the forecast period, while cell biology services have the highest market share in 2022.
Medicinal chemistry services dominate the global demand for drug discovery outsourcing, accounting for more than 55% in 2022.
The high-throughput screening (HTS) category will likely expand the fastest in the forecast timeline, while the structure-based drug design platforms had a market share of more than 58% in 2022.
With a more than 35% market share in 2022 and strong CAGR growth prospects, the oncology therapeutic area category will likely continue to lead the market needs for drug discovery outsourcing.
Pharmaceutical and biotechnology companies dominated the global market with 38% of the total revenue share by end-users.
North America contributes to the rapid development of the drug discovery outsourcing industry, accounting for more than one-third of the market in 2022, while Asia Pacific and Europe account for just under 54% of the market in 2022. In 2022, Europe had a market revenue share of more than 20%.
The growing complexity of drug discovery, including the increased need for specialized expertise in therapeutic areas like genomics, proteomics, and bioinformatics, has fueled the outsourcing market trend as companies seek external partners with specific capabilities.
CROs offer integrated services covering the entire drug development lifecycle, including discovery, preclinical development, clinical trials, and post-market surveillance, providing a one-stop market solution for pharmaceutical companies.

Executive Summary

Market Definition

Drug discovery is an intricate and time-consuming procedure that involves the identification, development, and screening of new treatments to treat different medical conditions. Target identification, lead optimization, lead discovery, preclinical testing, clinical trials, and regulatory approval are some of the stages that are usually involved in the process. Outsourcing entails contracting with a third-party organization to undertake any or every phase of the drug discovery process. It can also be used for regulatory approvals and clinical trials, although these are usually more complex and may require more specialized expertise. Chemical and biological services are the most frequently utilized forms of drug discovery outsourcing.

Outsourcing allows pharma and biotech companies to refrain from investing in costly laboratory equipment and specialized workers, resulting in lower overhead expenses. Outsourcing companies employ a team of highly qualified researchers and scientists who specialize in various areas of drug discovery. Outsourcing also assists businesses in gaining access to new technologies and procedures that they might have yet to be able to purchase or apply independently. All these benefits of drug discovery outsourcing drive industry growth.

Market Overview

The global drug discovery outsourcing market has shown remarkable growth in recent years and is projected to increase at a CAGR of 8% between 2023 and 2030. The market was valued at USD 3748.5 million in 2022 and is likely to reach USD 6938.2 million in 2030.

The pharmaceutical sector has undergone drastic changes in the last two decades, including a shift towards biologics, patent expiration, and unprecedented shrinking of big pharmaceutical internal discoveries. All of this has promoted the widespread acceptance of outsourcing activities. Players can focus on their core services by decomposing the many stages of drug development, such as hit confirmation, lead generation, optimization, and high-speed screening. An estimated 75% to 80% of R&D investment in the biopharma sector can be outsourced, offering opportunities for contract research organizations (CROs), which is predicted to facilitate drug discovery outsourcing market expansion.

According to a review paper published in the Indian Journal of Pharmacology in December 2022, outsourcing drug discovery services to CROs has become essential for cost and risk reduction, capacity growth, and data collection. As per the article, nearly one-third of all drug development procedures are outsourced globally, and data supplied by independent third parties is highly valued during regulatory submissions. As a result, drug discovery outsourcing will boost the success rate and speed of the drug development process, further propelling market growth throughout the projection timeframe.

Segmentation by Preclinical Services

The toxicology studies segment is anticipated to exhibit the highest CAGR, owing to the emerging need for comprehensive safety assessments in early-stage drug development.
Currently, the biochemical assays category leads the market share, accounting for over 40% in 2022, due to its crucial role in evaluating the efficacy and mechanism of action of potential drug candidates.

Segmentation by Chemistry Services

The analytical chemistry segment is poised to achieve the largest CAGR, attributed to the increasing emphasis on precise and advanced analytical techniques in drug development.
Medicinal chemistry services currently lead the market share with over 55% in 2022, underlining their pivotal role in designing and optimizing novel drug candidates.

Segmentation by Biology Services

Cell biology dominates within the biology services category, satisfying more than 52% of the global demand for drug discovery outsourcing in 2022. This dominance is attributed to its crucial role in elucidating cellular mechanisms and drug interactions.
Molecular biology services are expected to achieve a high market CAGR in the coming years, credited to the increasing focus on understanding genetic and molecular pathways in drug discovery.

Segmentation by Target Identification and Validation

The proteomic services category is expected to post a high market CAGR, attributed to the growing significance of proteomics in identifying potential drug targets.
Genomic services lead the market share with over 60% in 2022, owing to the important role of genomics in uncovering genetic factors associated with diseases and drug responses.

Segmentation by Clinical Research Services

The clinical monitoring segment is anticipated to register the largest CAGR, owing to the increasing complexity of clinical trials and the need for effective monitoring.
The clinical trial management category currently leads with a market share of nearly 62% in 2022, highlighting its integral role in overseeing and coordinating complex clinical trial processes.

Segmentation by Therapeutic Area

The neurology segment is projected to witness a high market CAGR, emphasizing the growing focus on neurological disorders and their treatment.
The oncology therapeutic area currently leads the global market share, holding over 35% in 2022, driven by the persistent demand for innovative cancer therapies.

Segmentation by End-User

Pharmaceutical and biotechnology companies dominate the global market share for drug discovery outsourcing, accounting for more than 38% in 2022. This prominence is attributed to the industry’s increasing reliance on outsourcing to streamline operations and access specialized expertise.
The rest of the market demands are derived from research and development (R&D) companies, highlighting the diverse ecosystem of stakeholders contributing to the drug discovery outsourcing market.

Segmentation by Region

North America stands out as a notably profitable region for industry players, accounting for over one-third of the share in 2022. The presence of major pharmaceutical firms, a robust regulatory framework, and a higher concentration of leading CROs fuel the regional dominance.
Europe and Asia Pacific contributed under 54% of the share in 2022, with Europe demonstrating a robust market presence exceeding 20%. Asia Pacific showcases major market growth potential, driven by its cost advantages, skilled workforce, and supportive regulatory environment.
The rest of the world, including Latin America, the Middle East, and Africa, fulfills the remaining demand for drug discovery outsourcing with diverse regional dynamics and growth opportunities. These regions present emerging markets and strategic opportunities for expanding the global footprint of drug discovery outsourcing services.

The growing number of partnerships in drug development research, the rise in the global prevalence of genetic, metabolic, and other chronic disorders, and technological advances in drug discovery are the main factors propelling the growth of the drug discovery outsourcing market size.

In 2022, North America held most of the revenue share in the global drug discovery outsourcing market. The region is home to a robust pharmaceutical and biotechnology industry, housing numerous established companies and a dynamic startup ecosystem. North America benefits from a well-developed infrastructure, a skilled workforce, and a long-standing tradition of R&D in the life sciences sector. Moreover, the region has a favorable regulatory environment that encourages innovation and facilitates efficient drug development processes. The presence of key drug discovery outsourcing hubs, such as the United States, where many leading CROs are headquartered, further solidifies regional dominance in the global market.

The Asia Pacific is anticipated to experience the most rapid growth of the drug discovery outsourcing industry. This region has emerged as a strategic hub for outsourcing due to its cost advantages, skilled scientific talent pool, and increasingly sophisticated infrastructure. Countries like India and China, in particular, have become major players in providing outsourcing services, offering a combination of lower operational costs and high-quality research capabilities. Moreover, supportive government initiatives, regulatory reforms, and the establishment of research-friendly environments also contribute to the regional attractiveness for drug discovery outsourcing.

Key Highlights of the Report

The global drug discovery outsourcing market is segmented by preclinical services, chemistry services, biology services, target identification and validation, clinical research services, therapeutic areas, end-users, technology platforms, contract models, and regions. The toxicology studies segment is estimated to grow significantly within preclinical services, addressing the escalating demand for rigorous safety assessments. In chemistry services, analytical chemistry is projected to lead in terms of market CAGR, owing to the increasing importance of precise analytical techniques in drug discovery. Oncology remains the leading therapeutic area, attributed to the continuous need for novel cancer treatment techniques.

The increase in the number of cases of chronic conditions such as heart disease, cancer, high blood pressure, diabetes, and others, a spike in R&D activities for drug development, and the surge in demands for target drug therapy are the key factors promoting drug discovery outsourcing market penetration. According to an IQVIA report published in June 2022, oncology trial starts attained historically high levels in 2021, up 56% from 2016 and primarily focused on rare cancer indications, and a record 30 oncology novel active substances initially launched globally in 2021, with a total of 159 launched since 2012. Thus, a sharp rise in the number of research activities elevates the requirement for clinical trials to bring a novel compound into the market, which increases the demand for outsourced service providers and thus supports drug discovery outsourcing market revenue growth.

North America is the largest regional market for drug discovery outsourcing, accounting for more than 38% of total revenue in 2022, while Europe is the second-largest global market. A well-established pharmaceutical sector, continuous R&D studies, higher R&D expenditures, expansion in the biosimilars and generics markets, and increasing outsourcing of R&D services by biotech businesses in the region are boosting North American market share. North America has the world’s largest pharmaceutical sector, with many global pharmaceutical and biopharmaceutical conglomerates headquartered there, including Charles River Laboratories International Inc., Thermo Fisher Scientific, Laboratory Corporation of America Holdings, Pfizer Inc., Abbott Laboratories, AbbVie Inc., Frontage Holdings, and Johnson & Johnson. These companies frequently outsource their drug discovery and development services to lower the cost and time required for drug development.

What Are The Main Drivers Of The Global Drug Discovery Outsourcing Market?

The growth of the global drug discovery outsourcing market is primarily driven by the increasing complexities and costs associated with in-house drug discovery processes, prompting biotech and pharma companies to leverage external expertise. Outsourcing offers a strategic solution to manage rising R&D expenses, enabling organizations to access a broader spectrum of specialized services and technologies. The growing emphasis on personalized medicine and the need for novel therapies contribute to expanding drug discovery activities, further propelling the outsourcing market share.

What Are The Major Challenges Faced By The Global Drug Discovery Outsourcing Market?

One of the primary market challenges is the increasing complexity of drug targets and the subsequent demand for highly specialized expertise. Quality assurance and data integrity are ongoing market concerns, especially as regulatory requirements become increasingly stringent. Besides, the unpredictable nature of clinical trials, regulatory uncertainties, and potential delays in the drug development process contribute to the overall risk landscape. Balancing cost considerations with the demand for high-quality services is another market barrier, as companies seek to optimize outsourcing expenditure without compromising on research standards.

What Are The Growth Opportunities In The Global Drug Discovery Outsourcing Market?

The emerging trend towards outsourcing non-core activities allows companies to focus on core competencies, thereby enhancing overall efficiency. The growing demand for specialized expertise in areas such as high-throughput screening, medicinal chemistry, and preclinical testing propels the expansion of outsourcing partnerships. Moreover, the surge in biopharmaceutical research and the development of biologics create a niche market for outsourcing services, particularly in bioprocessing and analytical testing. The rise of virtual biotech companies and small to mid-sized pharmaceutical firms, often with limited in-house resources, further drives the need for outsourced drug discovery services.

Market Drivers

Several factors are propelling the global drug discovery outsourcing market forward. The primary drivers of the global drug discovery outsourcing market growth are as follows:

Increased R&D Expenditure in Pharma-Biotech Sector

The pharmaceutical sector has seen a significant increase in R&D spending in recent years, owing to an upsurge in demands for innovative drugs for the treatment of a variety of diseases, a rise in the prevalence of chronic illnesses such as cancer and diabetes, and the emergence of novel therapies like as gene therapy and immunotherapy. However, drug discovery is a complex and long-consuming process that necessitates tremendous commitment in terms of money, time, and expertise.

According to ClinicalTrials.gov, the number of approved research studies increased at a CAGR of 4.2%, from 32,517 in 2019 to 36,770 in 2022. Companies in the biopharmaceutical and pharmaceutical sectors work continuously to discover new treatments. Biopharmaceutical firms heavily invest in R&D to produce novel, high-quality medicines to increase their market share. As per the recent report by Evaluate Pharma, global pharma R&D expenditure was valued at USD 144 billion in 2014 and is expected to reach USD 285 billion by 2028.

Pharmaceutical and biopharmaceutical businesses are increasingly choosing fully integrated or functional outsourcing services for drug discovery and development, from the early stages of research to the late stages of the process, due to their increasing R&D expenditures. Major pharmaceutical corporations are shifting to a leaner business strategy that relies primarily on outsourcing. Many biopharmaceutical businesses seek to outsource their testing activities during R&D to boost profitability, meet drug development timeframes, and save costs. Thus, rising R&D spending in the pharmaceutical industry supports the market expansion for drug discovery outsourcing.

Market Restraints

The global drug discovery outsourcing market faces challenges that may hinder its growth. These consist of the following:

Regulatory and Compliance Challenges

The primary priority of regulatory bodies during drug approval is ensuring safety and efficacy. Even if these procedures affirm the quality of medications introduced into the market, they greatly raise the expense of the drug manufacturing process of the final product. This aspect can substantially impact the uptake of certain medicines in regions with price-sensitive emerging markets. Aside from that, several legislations that govern product quality (such as GLP and GMP) frequently increase manufacturing costs.

The pharmaceutical industry is subject to a complex and evolving regulatory landscape, with different regions having distinct regulatory requirements. Ensuring that outsourced activities comply with various regulatory standards becomes a critical concern. Differences in interpretation or adherence to regulatory guidelines among outsourcing partners may lead to delays in the drug development process or even regulatory non-compliance. Failure to meet regulatory expectations can result in setbacks, additional costs, and potential risks to patient safety, posing a major constraint to the growth of the drug discovery outsourcing market.

Opportunities

The global drug discovery outsourcing market offers major growth opportunities. These consist of the following:

Technological Advancements and Integration of AI

The rapid evolution of technology, particularly the integration of AI and machine learning, presents a significant opportunity in drug discovery outsourcing. Advanced computational tools and algorithms enhance data analysis, allowing for more efficient target identification, lead optimization, and predictive modeling. AI-powered platforms can analyze vast datasets, identify patterns, and accelerate the drug discovery process. For example, in May 2023, Google Cloud released two new AI-powered tools to assist pharma and biotech companies in accelerating drug research. The suite is intended to assist pharmaceutical and biotech companies in identifying and comprehending the structure of proteins, which is an important element of the drug development process.

Pharmaceutical companies can leverage the expertise of outsourcing partners equipped with cutting-edge technologies to gain a competitive edge in drug development. The ongoing advancements in bioinformatics, chemoinformatics, and other computational approaches provide a fertile market ground for innovation and efficiency in drug discovery outsourcing.

Competitive Landscape

Key Players

The competitive landscape of the global drug discovery outsourcing market is marked by the presence of numerous contract research organizations (CROs) and service providers, each offering a range of specialized services across different stages of drug development. The following are some of the leading companies in the market, along with their market share:

Dalton Pharma Service
Syngene International Ltd
TCG Life Science Pvt. Ltd
Merck & Co.
Dr. Reddy’s Laboratories
Discover X Corporation
Laboratory Corporation of America Holdings
Curia Global Inc
Thermo Fisher Scientific Inc
Charles River Laboratories
Others

These major entities compete based on factors such as expertise, technological capabilities, service quality, and cost-effectiveness. Larger, established CROs often engage in strategic mergers and acquisitions to expand their service offerings and geographic reach, while smaller niche market players focus on specific therapeutic areas or technologies.

In February 2023, Related Sciences (U.S.) and Evotec SE (Germany) expanded the partnership to form a multi-target integrated drug discovery agreement. The two businesses set out to identify, research, and develop precisely targeted treatments for unmet patient needs.

In October 2022, Amphista Therapeutics, a biotechnology firm specializing in drug discovery projects utilizing targeted protein degradation (TPD), partnered with Domainex, a pharmaceutical research service partner, to deliver integrated drug discovery services for its clinical trial programs. Amphista will benefit from Domainex’s experience in protein manufacturing, medicinal chemistry, and assay biology.

In January 2022, Shanghai Fosun Pharmaceutical (Group) Co. Ltd signed a partnership agreement with Insilico Medicine, an end-to-end AI-driven drug research and development company, to accelerate the discovery and manufacturing of drugs focusing on various targets globally using AI technology.

Summary of Key Findings

The global drug discovery outsourcing market has been experiencing steady growth over the recent years, attributed to the increased demands for innovative therapies, complex drug development processes, and R&D cost containment strategies by pharmaceutical companies.
The market is segmented by preclinical services, chemistry services, biology services, target identification and validation, clinical research services, therapeutic area, end-user, technology platforms, contract models, and region.
CROs continue to dominate the drug discovery outsourcing market landscape, offering a wide range of services and expertise across different phases of drug development.
Outsourcing preclinical research services, including toxicology studies and animal testing, has gained market prominence as companies aim to streamline operations and reduce in-house infrastructure costs.
Cost containment remains a critical factor in the decision to outsource drug discovery activities, as companies seek to optimize resources and maintain competitiveness in the market.
The growth of the biotechnology sector has contributed to the expansion of the drug discovery outsourcing market, as both small and large biotech firms seek external expertise for various stages of drug development.

Future Outlook

The industry is increasingly adopting a patient-centric approach, with outsourcing partners focusing on patient recruitment strategies, real-world evidence generation, and patient-reported outcomes in clinical trials.
Integrating AI and ML algorithms is expected to play a major market role in streamlining drug discovery processes, enhancing data analysis, and facilitating more efficient target identification and lead optimization.
The Asia-Pacific region is anticipated to continue growing as a key outsourcing hub, with countries like India and China attracting pharmaceutical and biotech companies due to cost advantages, a skilled workforce, and supportive regulatory environments.

Segmentation

By Preclinical Services
- Biochemical Assays
- In vitro and In vivo Pharmacology
- Toxicology Studies
By Chemistry Services
- Medicinal Chemistry
- Analytical Chemistry
By Biology Services
- Cell Biology
- Molecular Biology
By Target Identification and Validation
- Genomic Services
- Proteomic Services
By Clinical Research Services
- Clinical Trial Management
- Clinical Monitoring
By Therapeutic Area
- Oncology
- Neurology
- Infectious Diseases
By End-User
- Pharmaceutical and Biotechnology Companies
- Government and Academic Institutions
- Research and Development (R&D) Companies
By Technology Platforms
- High-Throughput Screening (HTS)
- Structure-Based Drug Design
By Contract Models
- Full-Service Outsourcing
- Functional Service Outsourcing (FSO)
By Region
- North America
  - The U.S.
  - Canada
  - Mexico
- Europe
  - Germany
  - France
  - The U.K.
  - Italy
  - Spain
  - Rest of Europe
- Asia Pacific
  - China
  - Japan
  - India
  - South Korea
  - South-east Asia
  - Rest of Asia Pacific
- Latin America
  - Brazil
  - Argentina
  - Rest of Latin America
- Middle East & Africa
  - GCC Countries
  - South Africa
  - Rest of the Middle East and Africa

Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction

2. Executive Summary
2.1. Market Snapshot: Global Drug Discovery Outsourcing Market
2.1.1. Global Drug Discovery Outsourcing Market, By Preclinical Services
2.1.2. Global Drug Discovery Outsourcing Market, By Chemistry Services
2.1.3. Global Drug Discovery Outsourcing Market, By Biology Services
2.1.4. Global Drug Discovery Outsourcing Market, By Target Identification and Validation
2.1.5. Global Drug Discovery Outsourcing Market, By End-User
2.1.6. Global Drug Discovery Outsourcing Market, By Therapeutic Area
2.1.7. Global Drug Discovery Outsourcing Market, By Technology Platforms
2.1.8. Global Drug Discovery Outsourcing Market, By Clinical Research Services
2.1.9. Global Drug Discovery Outsourcing Market, By Contract Models
2.1.10. Global Drug Discovery Outsourcing Market, By Region
2.2. Insights from Primary Respondents

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Drug Discovery Outsourcing Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Drug Discovery Outsourcing Market Drivers
3.2.2. Drug Discovery Outsourcing Market Restraints
3.2.3. Drug Discovery Outsourcing Market Opportunities
3.2.4. Major Drug Discovery Outsourcing Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Preclinical Services
3.5.2. Chemistry Services
3.5.3. Biology Services
3.5.4. Target Identification and Validation
3.5.5. End-User
3.5.6. Therapeutic Area
3.5.7. Technology Platforms
3.5.8. Clinical Research Services
3.5.9. Contract Models
3.5.10. Geography

4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global Drug Discovery Outsourcing Market: Company Market Share, Value 2022
4.1.2. Global Drug Discovery Outsourcing Market: Top 6 Company Market Share, Value 2022
4.1.3. Global Drug Discovery Outsourcing Market: Top 3 Company Market Share, Value 2022
4.2. Global Drug Discovery Outsourcing Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Product Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Product Matrix
4.7. Potential for New Players in the Global Drug Discovery Outsourcing Market

5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Research and development in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis

6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Product Launch
6.5.5. Geographical Expansion
6.5.6. Others

7. Impact Analysis of COVID-19 and Russia – Ukraine War on Drug Discovery Outsourcing Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Product Mix
7.2.4. Reduced Industrial Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa

8. Global Drug Discovery Outsourcing Market, By Preclinical Services
8.1. Global Drug Discovery Outsourcing Market Overview, by Preclinical Services
8.1.1. Global Drug Discovery Outsourcing Market Revenue Share, By Preclinical Services, 2022 Vs 2030 (in %)
8.2. Biochemical Assays
8.2.1. Global Drug Discovery Outsourcing Market, By Biochemical Assays, By Region, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for Biochemical Assays
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. In vitro and In vivo Pharmacology
8.3.1. Global Drug Discovery Outsourcing Market, By In vitro and In vivo Pharmacology, By Region, 2017-2030 (US$ Mn)
8.3.2. Market Dynamics for In vitro and In vivo Pharmacology
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
8.4. Toxicology Studies
8.4.1. Global Drug Discovery Outsourcing Market, By Toxicology Studies, By Region, 2017-2030 (US$ Mn)
8.4.2. Market Dynamics for Toxicology Studies
8.4.2.1. Drivers
8.4.2.2. Restraints
8.4.2.3. Opportunities
8.4.2.4. Trends

9. Global Drug Discovery Outsourcing Market, By Chemistry Services
9.1. Global Drug Discovery Outsourcing Market Overview, by Chemistry Services
9.1.1. Global Drug Discovery Outsourcing Market Revenue Share, By Chemistry Services, 2022 Vs 2030 (in %)
9.2. Medicinal Chemistry
9.2.1. Global Drug Discovery Outsourcing Market, By Medicinal Chemistry, By Region, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for Medicinal Chemistry
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Analytical Chemistry
9.3.1. Global Drug Discovery Outsourcing Market, By Analytical Chemistry, By Region, 2017-2030 (US$ Mn)
9.3.2. Market Dynamics for Analytical Chemistry
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends

10. Global Drug Discovery Outsourcing Market, By Biology Services
10.1. Global Drug Discovery Outsourcing Market Overview, by Biology Services
10.1.1. Global Drug Discovery Outsourcing Market Revenue Share, By Biology Services, 2022 Vs 2030 (in %)
10.2. Cell Biology
10.2.1. Global Drug Discovery Outsourcing Market, By Cell Biology, By Region, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for Cell Biology
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Molecular Biology
10.3.1. Global Drug Discovery Outsourcing Market, By Molecular Biology, By Region, 2017-2030 (US$ Mn)
10.3.2. Market Dynamics for Molecular Biology
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends

11. Global Drug Discovery Outsourcing Market, By Target Identification and Validation
11.1. Global Drug Discovery Outsourcing Market Overview, by Target Identification and Validation
11.1.1. Global Drug Discovery Outsourcing Market Revenue Share, By Target Identification and Validation, 2022 Vs 2030 (in %)
11.2. Genomic Services
11.2.1. Global Drug Discovery Outsourcing Market, By Genomic Services, By Region, 2017-2030 (US$ Mn)
11.2.2. Market Dynamics for Genomic Services
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Proteomic Services
11.3.1. Global Drug Discovery Outsourcing Market, By Proteomic Services, By Region, 2017-2030 (US$ Mn)
11.3.2. Market Dynamics for Proteomic Services
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends

12. Global Drug Discovery Outsourcing Market, By End-User
12.1. Global Drug Discovery Outsourcing Market Overview, by End-User
12.1.1. Global Drug Discovery Outsourcing Market Revenue Share, By End-User, 2022 Vs 2030 (in %)
12.2. Pharmaceutical and Biotechnology Companies
12.2.1. Global Drug Discovery Outsourcing Market, By Pharmaceutical and Biotechnology Companies, By Region, 2017-2030 (US$ Mn)
12.2.2. Market Dynamics for Pharmaceutical and Biotechnology Companies
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Government and Academic Institutions
12.3.1. Global Drug Discovery Outsourcing Market, By Government and Academic Institutions, By Region, 2017-2030 (US$ Mn)
12.3.2. Market Dynamics for Government and Academic Institutions
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
12.4. Research and Development (R&D) Companies
12.4.1. Global Drug Discovery Outsourcing Market, By Research and Development (R&D) Companies, By Region, 2017-2030 (US$ Mn)
12.4.2. Market Dynamics for Research and Development (R&D) Companies
12.4.2.1. Drivers
12.4.2.2. Restraints
12.4.2.3. Opportunities
12.4.2.4. Trends

13. Global Drug Discovery Outsourcing Market, By Therapeutic Area
13.1. Global Drug Discovery Outsourcing Market Overview, by Therapeutic Area
13.1.1. Global Drug Discovery Outsourcing Market Revenue Share, By Therapeutic Area, 2022 Vs 2030 (in %)
13.2. Oncology
13.2.1. Global Drug Discovery Outsourcing Market, By Oncology, By Region, 2017-2030 (US$ Mn)
13.2.2. Market Dynamics for Oncology
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
13.3. Neurology
13.3.1. Global Drug Discovery Outsourcing Market, By Neurology, By Region, 2017-2030 (US$ Mn)
13.3.2. Market Dynamics for Neurology
13.3.2.1. Drivers
13.3.2.2. Restraints
13.3.2.3. Opportunities
13.3.2.4. Trends
13.4. Infectious Diseases
13.4.1. Global Drug Discovery Outsourcing Market, By Infectious Diseases, By Region, 2017-2030 (US$ Mn)
13.4.2. Market Dynamics for Infectious Diseases
13.4.2.1. Drivers
13.4.2.2. Restraints
13.4.2.3. Opportunities
13.4.2.4. Trends

14. Global Drug Discovery Outsourcing Market, By Technology Platforms
14.1. Global Drug Discovery Outsourcing Market Overview, by Technology Platforms
14.1.1. Global Drug Discovery Outsourcing Market Revenue Share, By Technology Platforms, 2022 Vs 2030 (in %)
14.2. Structure-Based Drug Design
14.2.1. Global Drug Discovery Outsourcing Market, By Structure-Based Drug Design, By Region, 2017-2030 (US$ Mn)
14.2.2. Market Dynamics for Structure-Based Drug Design
14.2.2.1. Drivers
14.2.2.2. Restraints
14.2.2.3. Opportunities
14.2.2.4. Trends
14.3. High-Throughput Screening (HTS)
14.3.1. Global Drug Discovery Outsourcing Market, By High-Throughput Screening (HTS), By Region, 2017-2030 (US$ Mn)
14.3.2. Market Dynamics for High-Throughput Screening (HTS)
14.3.2.1. Drivers
14.3.2.2. Restraints
14.3.2.3. Opportunities
14.3.2.4. Trends

15. Global Drug Discovery Outsourcing Market, By Clinical Research Services
15.1. Global Drug Discovery Outsourcing Market Overview, by Clinical Research Services
15.1.1. Global Drug Discovery Outsourcing Market Revenue Share, By Clinical Research Services, 2022 Vs 2030 (in %)
15.2. Clinical Trial Management
15.2.1. Global Drug Discovery Outsourcing Market, By Clinical Trial Management, By Region, 2017-2030 (US$ Mn)
15.2.2. Market Dynamics for Clinical Trial Management
15.2.2.1. Drivers
15.2.2.2. Restraints
15.2.2.3. Opportunities
15.2.2.4. Trends
15.3. Clinical Monitoring
15.3.1. Global Drug Discovery Outsourcing Market, By Clinical Monitoring, By Region, 2017-2030 (US$ Mn)
15.3.2. Market Dynamics for Clinical Monitoring
15.3.2.1. Drivers
15.3.2.2. Restraints
15.3.2.3. Opportunities
15.3.2.4. Trends

16. Global Drug Discovery Outsourcing Market, By Contract Models
16.1. Global Drug Discovery Outsourcing Market Overview, by Contract Models
16.1.1. Global Drug Discovery Outsourcing Market Revenue Share, By Contract Models, 2022 Vs 2030 (in %)
16.2. Full-Service Outsourcing
16.2.1. Global Drug Discovery Outsourcing Market, By Full-Service Outsourcing, By Region, 2017-2030 (US$ Mn)
16.2.2. Market Dynamics for Full-Service Outsourcing
16.2.2.1. Drivers
16.2.2.2. Restraints
16.2.2.3. Opportunities
16.2.2.4. Trends
16.3. Functional Service Outsourcing (FSO)
16.3.1. Global Drug Discovery Outsourcing Market, By Functional Service Outsourcing (FSO), By Region, 2017-2030 (US$ Mn)
16.3.2. Market Dynamics for Functional Service Outsourcing (FSO)
16.3.2.1. Drivers
16.3.2.2. Restraints
16.3.2.3. Opportunities
16.3.2.4. Trends

17. Global Drug Discovery Outsourcing Market, By Region
17.1. Global Drug Discovery Outsourcing Market Overview, by Region
17.1.1. Global Drug Discovery Outsourcing Market, By Region, 2022 vs 2030 (in%)
17.2. Preclinical Services
17.2.1. Global Drug Discovery Outsourcing Market, By Preclinical Services, 2017-2030 (US$ Mn)
17.3. Chemistry Services
17.3.1. Global Drug Discovery Outsourcing Market, By Chemistry Services, 2017-2030 (US$ Mn)
17.4. Biology Services
17.4.1. Global Drug Discovery Outsourcing Market, By Biology Services, 2017-2030 (US$ Mn)
17.5. Target Identification and Validation
17.5.1. Global Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2030 (US$ Mn)
17.6. End-User
17.6.1. Global Drug Discovery Outsourcing Market, By End-User, 2017-2030 (US$ Mn)
17.7. Therapeutic Area
17.7.1. Global Drug Discovery Outsourcing Market, By Therapeutic Area, 2017-2030 (US$ Mn)
17.8. Technology Platforms
17.8.1. Global Drug Discovery Outsourcing Market, By Technology Platforms, 2017-2030 (US$ Mn)
17.9. Clinical Research Services
17.9.1. Global Drug Discovery Outsourcing Market, By Clinical Research Services, 2017-2030 (US$ Mn)
17.10. Contract Models
17.10.1. Global Drug Discovery Outsourcing Market, By Contract Models, 2017-2030 (US$ Mn)

18. North America Drug Discovery Outsourcing Market Analysis
18.1. Overview
18.1.1. Market Dynamics for North America
18.1.1.1. Drivers
18.1.1.2. Restraints
18.1.1.3. Opportunities
18.1.1.4. Trends
18.2. North America Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2030(US$ Mn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. North America Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2030(US$ Mn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. North America Drug Discovery Outsourcing Market, by Biology Services, 2017-2030(US$ Mn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. North America Drug Discovery Outsourcing Market, by Target Identification and Validation, 2017-2030(US$ Mn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. North America Drug Discovery Outsourcing Market, by End-User, 2017-2030(US$ Mn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. North America Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2030(US$ Mn)
18.7.1. Overview
18.7.2. SRC Analysis
18.8. North America Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2030(US$ Mn)
18.8.1. Overview
18.8.2. SRC Analysis
18.9. North America Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2030(US$ Mn)
18.9.1. Overview
18.9.2. SRC Analysis
18.10. North America Drug Discovery Outsourcing Market, by Contract Models, 2017-2030(US$ Mn)
18.10.1. Overview
18.10.2. SRC Analysis
18.11. North America Drug Discovery Outsourcing Market, by Country, 2017-2030 (US$ Mn)
18.11.1. North America Drug Discovery Outsourcing Market, by Country, 2022 Vs 2030 (in%)
18.11.2. U.S.
18.11.3. Canada
18.11.4. Mexico

19. Europe Drug Discovery Outsourcing Market Analysis
19.1. Overview
19.1.1. Market Dynamics for North America
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. Europe Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2030(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Europe Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2030(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Europe Drug Discovery Outsourcing Market, by Biology Services, 2017-2030(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Europe Drug Discovery Outsourcing Market, by Target Identification and Validation, 2017-2030(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Europe Drug Discovery Outsourcing Market, by End-User, 2017-2030(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Europe Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2030(US$ Mn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. Europe Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2030(US$ Mn)
19.8.1. Overview
19.8.2. SRC Analysis
19.9. Europe Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2030(US$ Mn)
19.9.1. Overview
19.9.2. SRC Analysis
19.10. Europe Drug Discovery Outsourcing Market, by Contract Models, 2017-2030(US$ Mn)
19.10.1. Overview
19.10.2. SRC Analysis
19.11. Europe Drug Discovery Outsourcing Market, by Country, 2017-2030 (US$ Mn)
19.11.1. Europe Drug Discovery Outsourcing Market, by Country, 2022 Vs 2030 (in%)
19.11.2. UK
19.11.3. France
19.11.4. Germany
19.11.5. Italy
19.11.6. Spain
19.11.7. Benelux
19.11.8. Russia
19.11.9. Rest of Europe

20. Asia Pacific Drug Discovery Outsourcing Market Analysis
20.1. Overview
20.1.1. Market Dynamics for North America
20.1.1.1. Drivers
20.1.1.2. Restraints
20.1.1.3. Opportunities
20.1.1.4. Trends
20.2. Asia Pacific Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2030(US$ Mn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Asia Pacific Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2030(US$ Mn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Asia Pacific Drug Discovery Outsourcing Market, by Biology Services, 2017-2030(US$ Mn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Asia Pacific Drug Discovery Outsourcing Market, by Target Identification and Validation, 2017-2030(US$ Mn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Asia Pacific Drug Discovery Outsourcing Market, by End-User, 2017-2030(US$ Mn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Asia Pacific Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2030(US$ Mn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Asia Pacific Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2030(US$ Mn)
20.8.1. Overview
20.8.2. SRC Analysis
20.9. Asia Pacific Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2030(US$ Mn)
20.9.1. Overview
20.9.2. SRC Analysis
20.10. Asia Pacific Drug Discovery Outsourcing Market, by Contract Models, 2017-2030(US$ Mn)
20.10.1. Overview
20.10.2. SRC Analysis
20.11. Asia Pacific Drug Discovery Outsourcing Market, by Country, 2017-2030 (US$ Mn)
20.11.1. Asia Pacific Drug Discovery Outsourcing Market, by Country, 2022 Vs 2030 (in%)
20.11.2. China
20.11.3. Japan
20.11.4. India
20.11.5. South Korea
20.11.6. South East Asia
20.11.7. Rest of Asia Pacific

21. Latin America Drug Discovery Outsourcing Market Analysis
21.1. Overview
21.1.1. Market Dynamics for North America
21.1.1.1. Drivers
21.1.1.2. Restraints
21.1.1.3. Opportunities
21.1.1.4. Trends
21.2. Latin America Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2030(US$ Mn)
21.2.1. Overview
21.2.2. SRC Analysis
21.3. Latin America Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2030(US$ Mn)
21.3.1. Overview
21.3.2. SRC Analysis
21.4. Latin America Drug Discovery Outsourcing Market, by Biology Services, 2017-2030(US$ Mn)
21.4.1. Overview
21.4.2. SRC Analysis
21.5. Latin America Drug Discovery Outsourcing Market, by Target Identification and Validation, 2017-2030(US$ Mn)
21.5.1. Overview
21.5.2. SRC Analysis
21.6. Latin America Drug Discovery Outsourcing Market, by End-User, 2017-2030(US$ Mn)
21.6.1. Overview
21.6.2. SRC Analysis
21.7. Latin America Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2030(US$ Mn)
21.7.1. Overview
21.7.2. SRC Analysis
21.8. Latin America Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2030(US$ Mn)
21.8.1. Overview
21.8.2. SRC Analysis
21.9. Latin America Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2030(US$ Mn)
21.9.1. Overview
21.9.2. SRC Analysis
21.10. Latin America Drug Discovery Outsourcing Market, by Contract Models, 2017-2030(US$ Mn)
21.10.1. Overview
21.10.2. SRC Analysis
21.11. Latin America Drug Discovery Outsourcing Market, by Country, 2017-2030 (US$ Mn)
21.11.1. Latin America Drug Discovery Outsourcing Market, by Country, 2022 Vs 2030 (in%)
21.11.2. Brazil
21.11.3. Argentina
21.11.4. Rest of Latin America

22. Middle East Drug Discovery Outsourcing Market Analysis
22.1. Overview
22.1.1. Market Dynamics for North America
22.1.1.1. Drivers
22.1.1.2. Restraints
22.1.1.3. Opportunities
22.1.1.4. Trends
22.2. Middle East Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2030(US$ Mn)
22.2.1. Overview
22.2.2. SRC Analysis
22.3. Middle East Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2030(US$ Mn)
22.3.1. Overview
22.3.2. SRC Analysis
22.4. Middle East Drug Discovery Outsourcing Market, by Biology Services, 2017-2030(US$ Mn)
22.4.1. Overview
22.4.2. SRC Analysis
22.5. Middle East Drug Discovery Outsourcing Market, by Target Identification and Validation, 2017-2030(US$ Mn)
22.5.1. Overview
22.5.2. SRC Analysis
22.6. Middle East Drug Discovery Outsourcing Market, by End-User, 2017-2030(US$ Mn)
22.6.1. Overview
22.6.2. SRC Analysis
22.7. Middle East Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2030(US$ Mn)
22.7.1. Overview
22.7.2. SRC Analysis
22.8. Middle East Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2030(US$ Mn)
22.8.1. Overview
22.8.2. SRC Analysis
22.9. Middle East Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2030(US$ Mn)
22.9.1. Overview
22.9.2. SRC Analysis
22.10. Middle East Drug Discovery Outsourcing Market, by Contract Models, 2017-2030(US$ Mn)
22.10.1. Overview
22.10.2. SRC Analysis
22.11. Middle East Drug Discovery Outsourcing Market, by Country, 2017-2030 (US$ Mn)
22.11.1. Middle East Drug Discovery Outsourcing Market, by Country, 2022 Vs 2030 (in%)
22.11.2. UAE
22.11.3. Saudi Arabia
22.11.4. Rest of Middle East

23. Africa Drug Discovery Outsourcing Market Analysis
23.1. Overview
23.1.1. Market Dynamics for North America
23.1.1.1. Drivers
23.1.1.2. Restraints
23.1.1.3. Opportunities
23.1.1.4. Trends
23.2. Africa Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2030(US$ Mn)
23.2.1. Overview
23.2.2. SRC Analysis
23.3. Africa Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2030(US$ Mn)
23.3.1. Overview
23.3.2. SRC Analysis
23.4. Africa Drug Discovery Outsourcing Market, by Biology Services, 2017-2030(US$ Mn)
23.4.1. Overview
23.4.2. SRC Analysis
23.5. Africa Drug Discovery Outsourcing Market, by Target Identification and Validation, 2017-2030(US$ Mn)
23.5.1. Overview
23.5.2. SRC Analysis
23.6. Africa Drug Discovery Outsourcing Market, by End-User, 2017-2030(US$ Mn)
23.6.1. Overview
23.6.2. SRC Analysis
23.7. Africa Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2030(US$ Mn)
23.7.1. Overview
23.7.2. SRC Analysis
23.8. Africa Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2030(US$ Mn)
23.8.1. Overview
23.8.2. SRC Analysis
23.9. Africa Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2030(US$ Mn)
23.9.1. Overview
23.9.2. SRC Analysis
23.10. Africa Drug Discovery Outsourcing Market, by Contract Models, 2017-2030(US$ Mn)
23.10.1. Overview
23.10.2. SRC Analysis
23.11. Africa Drug Discovery Outsourcing Market, by Country, 2017-2030 (US$ Mn)
23.11.1. Middle East Drug Discovery Outsourcing Market, by Country, 2022 Vs 2030 (in%)
23.11.2. South Africa
23.11.3. Egypt
23.11.4. Rest of Africa

24. Company Profiles
24.1. Dalton Pharma Service
24.1.1. Company Overview
24.1.2. Products/Services Portfolio
24.1.3. Geographical Presence
24.1.4. SWOT Analysis
24.1.5. Financial Summary
24.1.5.1. Market Revenue and Net Profit (2019-2022)
24.1.5.2. Business Segment Revenue Analysis
24.1.5.3. Geographical Revenue Analysis
24.2. Syngene International Ltd
24.3. TCG Life Science Pvt. Ltd
24.4. Merck & Co.
24.5. Dr. Reddy’s Laboratories
24.6. Discover X Corporation
24.7. Laboratory Corporation of America Holdings
24.8. Curia Global Inc
24.9. Thermo Fisher Scientific Inc
24.10. Charles River Laboratories
24.11. Others
25. Research Methodology
25.1. Research Methodology
25.2. Phase I – Secondary Research
25.3. Phase II – Data Modelling
25.3.1. Company Share Analysis Model
25.3.2. Revenue Based Modelling
25.4. Phase III – Primary Research
25.5. Research Limitations
25.5.1. Assumptions
List of Figures
FIG. 1 Global Drug Discovery Outsourcing Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom Up Approach
FIG. 3 Global Drug Discovery Outsourcing Market Segmentation
FIG. 4 Global Drug Discovery Outsourcing Market, by Preclinical Services, 2022 (US$ Mn)
FIG. 5 Global Drug Discovery Outsourcing Market, by Chemistry Services, 2022 (US$ Mn)
FIG. 6 Global Drug Discovery Outsourcing Market, by Biology Services, 2022 (US$ Mn)
FIG. 7 Global Drug Discovery Outsourcing Market, by Target Identification and Validation, 2022 (US$ Mn)
FIG. 8 Global Drug Discovery Outsourcing Market, by End-User, 2022 (US$ Mn)
FIG. 9 Global Drug Discovery Outsourcing Market, by Therapeutic Area, 2022 (US$ Mn)
FIG. 10 Global Drug Discovery Outsourcing Market, by Technology Platforms, 2022 (US$ Mn)
FIG. 11 Global Drug Discovery Outsourcing Market, by Clinical Research Services, 2022 (US$ Mn)
FIG. 12 Global Drug Discovery Outsourcing Market, by Contract Models, 2022 (US$ Mn)
FIG. 13 Global Drug Discovery Outsourcing Market, by Geography, 2022 (US$ Mn)
FIG. 14 Attractive Investment Proposition, by Preclinical Services, 2022
FIG. 15 Attractive Investment Proposition, by Chemistry Services, 2022
FIG. 16 Attractive Investment Proposition, by Biology Services, 2022
FIG. 17 Attractive Investment Proposition, by Target Identification and Validation, 2022
FIG. 18 Attractive Investment Proposition, by End-User, 2022
FIG. 19 Attractive Investment Proposition, by Therapeutic Area, 2022
FIG. 20 Attractive Investment Proposition, by Technology Platforms, 2022
FIG. 21 Attractive Investment Proposition, by Clinical Research Services, 2022
FIG. 22 Attractive Investment Proposition, by Contract Models, 2022
FIG. 23 Attractive Investment Proposition, by Geography, 2022
FIG. 24 Global Market Share Analysis of Key Drug Discovery Outsourcing Market Manufacturers, 2022
FIG. 25 Global Market Positioning of Key Drug Discovery Outsourcing Market Manufacturers, 2022
FIG. 26 Global Drug Discovery Outsourcing Market Value Contribution, By Preclinical Services, 2022 & 2030 (Value %)
FIG. 27 Global Drug Discovery Outsourcing Market, by Biochemical Assays, Value, 2017-2030 (US$ Mn)
FIG. 28 Global Drug Discovery Outsourcing Market, by In vitro and In vivo Pharmacology, Value, 2017-2030 (US$ Mn)
FIG. 29 Global Drug Discovery Outsourcing Market, by Toxicology Studies, Value, 2017-2030 (US$ Mn)
FIG. 30 Global Drug Discovery Outsourcing Market Value Contribution, By Chemistry Services, 2022 & 2030 (Value %)
FIG. 31 Global Drug Discovery Outsourcing Market, by Medicinal Chemistry, Value, 2017-2030 (US$ Mn)
FIG. 32 Global Drug Discovery Outsourcing Market, by Analytical Chemistry, Value, 2017-2030 (US$ Mn)
FIG. 33 Global Drug Discovery Outsourcing Market Value Contribution, By Biology Services, 2022 & 2030 (Value %)
FIG. 34 Global Drug Discovery Outsourcing Market, by Cell Biology, Value, 2017-2030 (US$ Mn)
FIG. 35 Global Drug Discovery Outsourcing Market, by Molecular Biology, Value, 2017-2030 (US$ Mn)
FIG. 36 Global Drug Discovery Outsourcing Market Value Contribution, By Target Identification and Validation, 2022 & 2030 (Value %)
FIG. 37 Global Drug Discovery Outsourcing Market, by Genomic Services, Value, 2017-2030 (US$ Mn)
FIG. 38 Global Drug Discovery Outsourcing Market, by Proteomic Services, Value, 2017-2030 (US$ Mn)
FIG. 39 Global Drug Discovery Outsourcing Market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 40 Global Drug Discovery Outsourcing Market, by Pharmaceutical and Biotechnology Companies, Value, 2017-2030 (US$ Mn)
FIG. 41 Global Drug Discovery Outsourcing Market, by Government and Academic Institutions, Value, 2017-2030 (US$ Mn)
FIG. 42 Global Drug Discovery Outsourcing Market, by Research and Development (R&D) Companies, Value, 2017-2030 (US$ Mn)
FIG. 43 Global Drug Discovery Outsourcing Market Value Contribution, By Therapeutic Area, 2022 & 2030 (Value %)
FIG. 44 Global Drug Discovery Outsourcing Market, by Oncology, Value, 2017-2030 (US$ Mn)
FIG. 45 Global Drug Discovery Outsourcing Market, by Neurology, Value, 2017-2030 (US$ Mn)
FIG. 46 Global Drug Discovery Outsourcing Market, by Infectious Diseases, Value, 2017-2030 (US$ Mn)
FIG. 47 Global Drug Discovery Outsourcing Market Value Contribution, By Technology Platforms, 2022 & 2030 (Value %)
FIG. 48 Global Drug Discovery Outsourcing Market, by Structure-Based Drug Design, Value, 2017-2030 (US$ Mn)
FIG. 49 Global Drug Discovery Outsourcing Market, by High-Throughput Screening (HTS), Value, 2017-2030 (US$ Mn)
FIG. 50 Global Drug Discovery Outsourcing Market Value Contribution, By Clinical Research Services, 2022 & 2030 (Value %)
FIG. 51 Global Drug Discovery Outsourcing Market, by Clinical Trial Management, Value, 2017-2030 (US$ Mn)
FIG. 52 Global Drug Discovery Outsourcing Market, by Clinical Monitoring, Value, 2017-2030 (US$ Mn)
FIG. 53 Global Drug Discovery Outsourcing Market Value Contribution, By Contract Models, 2022 & 2030 (Value %)
FIG. 54 Global Drug Discovery Outsourcing Market, by Full-Service Outsourcing, Value, 2017-2030 (US$ Mn)
FIG. 55 Global Drug Discovery Outsourcing Market, by Functional Service Outsourcing (FSO), Value, 2017-2030 (US$ Mn)
FIG. 56 North America Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 57 U.S. Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 58 Canada Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 59 Mexico Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 60 Europe Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 61 Germany Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 62 France Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 63 U.K. Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 64 Italy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 65 Spain Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 66 Benelux Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 67 Russia Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 68 Rest of Europe Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 69 Asia Pacific Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 70 China Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 71 Japan Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 72 India Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 73 South Korea Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 74 South-East Asia Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 75 Rest of Asia Pacific Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 76 Latin America Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 77 Brazil Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 78 Argentina Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 79 Rest of Latin America Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 80 Middle East Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 81 UAE Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 82 Saudi Arabia Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 83 Rest of Middle East Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 84 Africa Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 85 South Africa Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 86 Egypt Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 87 Rest of Africa Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
List of Tables
TABLE 1 Market Snapshot: Global Drug Discovery Outsourcing Market
TABLE 2 Global Drug Discovery Outsourcing Market: Market Drivers Impact Analysis
TABLE 3 Global Drug Discovery Outsourcing Market: Market Restraints Impact Analysis
TABLE 4 Global Drug Discovery Outsourcing Market, by Competitive Benchmarking, 2022
TABLE 5 Global Drug Discovery Outsourcing Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Drug Discovery Outsourcing Market, by Key Strategies Analysis, 2022
TABLE 7 Global Drug Discovery Outsourcing Market, by Biochemical Assays, By Region, 2017-2022 (US$ Mn)
TABLE 8 Global Drug Discovery Outsourcing Market, by Biochemical Assays, By Region, 2023-2030 (US$ Mn)
TABLE 9 Global Drug Discovery Outsourcing Market, by In vitro and In vivo Pharmacology, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global Drug Discovery Outsourcing Market, by In vitro and In vivo Pharmacology, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global Drug Discovery Outsourcing Market, by Toxicology Studies, By Region, 2017-2022 (US$ Mn)
TABLE 12 Global Drug Discovery Outsourcing Market, by Toxicology Studies, By Region, 2023-2030 (US$ Mn)
TABLE 13 Global Drug Discovery Outsourcing Market, by Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global Drug Discovery Outsourcing Market, by Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global Drug Discovery Outsourcing Market, by Analytical Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global Drug Discovery Outsourcing Market, by Analytical Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global Drug Discovery Outsourcing Market, by Cell Biology, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global Drug Discovery Outsourcing Market, by Cell Biology, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global Drug Discovery Outsourcing Market, by Molecular Biology, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global Drug Discovery Outsourcing Market, by Molecular Biology, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global Drug Discovery Outsourcing Market, by Genomic Services, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global Drug Discovery Outsourcing Market, by Genomic Services, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global Drug Discovery Outsourcing Market, by Proteomic Services, By Region, 2017-2022 (US$ Mn)
TABLE 24 Global Drug Discovery Outsourcing Market, by Proteomic Services, By Region, 2023-2030 (US$ Mn)
TABLE 25 Global Drug Discovery Outsourcing Market, by Pharmaceutical and Biotechnology Companies, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global Drug Discovery Outsourcing Market, by Pharmaceutical and Biotechnology Companies, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global Drug Discovery Outsourcing Market, by Government and Academic Institutions, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global Drug Discovery Outsourcing Market, by Government and Academic Institutions, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global Drug Discovery Outsourcing Market, by Research and Development (R&D) Companies, By Region, 2017-2022 (US$ Mn)
TABLE 30 Global Drug Discovery Outsourcing Market, by Research and Development (R&D) Companies, By Region, 2023-2030 (US$ Mn)
TABLE 31 Global Drug Discovery Outsourcing Market, by Oncology, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global Drug Discovery Outsourcing Market, by Oncology, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global Drug Discovery Outsourcing Market, by Neurology, By Region, 2017-2022 (US$ Mn)
TABLE 34 Global Drug Discovery Outsourcing Market, by Neurology, By Region, 2023-2030 (US$ Mn)
TABLE 35 Global Drug Discovery Outsourcing Market, by Infectious Diseases, By Region, 2017-2022 (US$ Mn)
TABLE 36 Global Drug Discovery Outsourcing Market, by Infectious Diseases, By Region, 2023-2030 (US$ Mn)
TABLE 37 Global Drug Discovery Outsourcing Market, by Structure-Based Drug Design, By Region, 2017-2022 (US$ Mn)
TABLE 38 Global Drug Discovery Outsourcing Market, by Structure-Based Drug Design, By Region, 2023-2030 (US$ Mn)
TABLE 39 Global Drug Discovery Outsourcing Market, by High-Throughput Screening (HTS), By Region, 2017-2022 (US$ Mn)
TABLE 40 Global Drug Discovery Outsourcing Market, by High-Throughput Screening (HTS), By Region, 2023-2030 (US$ Mn)
TABLE 41 Global Drug Discovery Outsourcing Market, by Clinical Trial Management, By Region, 2017-2022 (US$ Mn)
TABLE 42 Global Drug Discovery Outsourcing Market, by Clinical Trial Management, By Region, 2023-2030 (US$ Mn)
TABLE 43 Global Drug Discovery Outsourcing Market, by Clinical Monitoring, By Region, 2017-2022 (US$ Mn)
TABLE 44 Global Drug Discovery Outsourcing Market, by Clinical Monitoring, By Region, 2023-2030 (US$ Mn)
TABLE 45 Global Drug Discovery Outsourcing Market, by Functional Service Outsourcing (FSO), By Region, 2017-2022 (US$ Mn)
TABLE 46 Global Drug Discovery Outsourcing Market, by Functional Service Outsourcing (FSO), By Region, 2023-2030 (US$ Mn)
TABLE 47 Global Drug Discovery Outsourcing Market, by Full-Service Outsourcing, By Region, 2017-2022 (US$ Mn)
TABLE 48 Global Drug Discovery Outsourcing Market, by Full-Service Outsourcing, By Region, 2023-2030 (US$ Mn)
TABLE 49 Global Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 50 Global Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 51 Global Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 52 Global Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 53 Global Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 54 Global Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 55 Global Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 56 Global Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 57 Global Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 58 Global Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 59 Global Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 60 Global Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 61 Global Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 62 Global Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 63 Global Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 64 Global Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 65 Global Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 66 Global Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 67 Global Drug Discovery Outsourcing Market, by Region, 2017-2022 (US$ Mn)
TABLE 68 Global Drug Discovery Outsourcing Market, by Region, 2023-2030 (US$ Mn)
TABLE 69 North America Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 70 North America Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 71 North America Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 72 North America Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 73 North America Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 74 North America Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 75 North America Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 76 North America Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 77 North America Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 78 North America Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 79 North America Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 80 North America Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 81 North America Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 82 North America Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 83 North America Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 84 North America Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 85 North America Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 86 North America Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 87 North America Drug Discovery Outsourcing Market, by Country, 2017-2022 (US$ Mn)
TABLE 88 North America Drug Discovery Outsourcing Market, by Country, 2023-2030 (US$ Mn)
TABLE 89 United States Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 90 United States Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 91 United States Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 92 United States Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 93 United States Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 94 United States Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 95 United States Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 96 United States Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 97 United States Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 98 United States Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 99 United States Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 100 United States Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 101 United States Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 102 United States Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 103 United States Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 104 United States Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 105 United States Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 106 United States Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 107 Canada Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 108 Canada Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 109 Canada Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 110 Canada Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 111 Canada Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 112 Canada Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 113 Canada Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 114 Canada Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 115 Canada Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 116 Canada Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 117 Canada Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 118 Canada Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 119 Canada Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 120 Canada Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 121 Canada Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 122 Canada Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 123 Canada Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 124 Canada Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 125 Mexico Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 126 Mexico Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 127 Mexico Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 128 Mexico Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 129 Mexico Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 130 Mexico Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 131 Mexico Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 132 Mexico Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 133 Mexico Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 134 Mexico Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 135 Mexico Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 136 Mexico Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 137 Mexico Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 138 Mexico Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 139 Mexico Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 140 Mexico Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 141 Mexico Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 142 Mexico Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 143 Europe Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 144 Europe Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 145 Europe Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 146 Europe Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 147 Europe Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 148 Europe Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 149 Europe Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 150 Europe Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 151 Europe Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 152 Europe Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 153 Europe Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 154 Europe Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 155 Europe Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 156 Europe Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 157 Europe Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 158 Europe Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 159 Europe Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 160 Europe Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 161 Europe Drug Discovery Outsourcing Market, by Country, 2017-2022 (US$ Mn)
TABLE 162 Europe Drug Discovery Outsourcing Market, by Country, 2023-2030 (US$ Mn)
TABLE 163 Germany Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 164 Germany Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 165 Germany Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 166 Germany Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 167 Germany Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 168 Germany Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 169 Germany Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 170 Germany Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 171 Germany Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 172 Germany Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 173 Germany Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 174 Germany Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 175 Germany Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 176 Germany Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 177 Germany Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 178 Germany Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 179 Germany Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 180 Germany Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 181 France Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 182 France Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 183 France Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 184 France Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 185 France Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 186 France Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 187 France Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 188 France Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 189 France Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 190 France Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 191 France Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 192 France Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 193 France Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 194 France Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 195 France Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 196 France Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 197 France Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 198 France Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 199 United Kingdom Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 200 United Kingdom Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 201 United Kingdom Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 202 United Kingdom Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 203 United Kingdom Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 204 United Kingdom Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 205 United Kingdom Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 206 United Kingdom Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 207 United Kingdom Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 208 United Kingdom Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 209 United Kingdom Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 210 United Kingdom Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 211 United Kingdom Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 212 United Kingdom Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 213 United Kingdom Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 214 United Kingdom Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 215 United Kingdom Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 216 United Kingdom Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 217 Italy Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 218 Italy Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 219 Italy Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 220 Italy Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 221 Italy Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 222 Italy Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 223 Italy Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 224 Italy Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 225 Italy Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 226 Italy Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 227 Italy Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 228 Italy Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 229 Italy Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 230 Italy Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 231 Italy Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 232 Italy Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 233 Italy Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 234 Italy Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 235 Spain Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 236 Spain Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 237 Spain Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 238 Spain Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 239 Spain Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 240 Spain Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 241 Spain Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 242 Spain Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 243 Spain Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 244 Spain Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 245 Spain Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 246 Spain Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 247 Spain Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 248 Spain Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 249 Spain Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 250 Spain Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 251 Spain Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 252 Spain Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 253 Benelux Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 254 Benelux Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 255 Benelux Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 256 Benelux Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 257 Benelux Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 258 Benelux Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 259 Benelux Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 260 Benelux Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 261 Benelux Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 262 Benelux Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 263 Benelux Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 264 Benelux Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 265 Benelux Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 266 Benelux Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 267 Benelux Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 268 Benelux Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 269 Benelux Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 270 Benelux Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 271 Russia Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 272 Russia Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 273 Russia Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 274 Russia Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 275 Russia Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 276 Russia Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 277 Russia Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 278 Russia Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 279 Russia Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 280 Russia Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 281 Russia Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 282 Russia Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 283 Russia Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 284 Russia Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 285 Russia Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 286 Russia Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 287 Russia Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 288 Russia Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 289 Rest of Europe Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 290 Rest of Europe Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 291 Rest of Europe Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 292 Rest of Europe Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 293 Rest of Europe Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 294 Rest of Europe Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 295 Rest of Europe Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 296 Rest of Europe Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 297 Rest of Europe Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 298 Rest of Europe Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 299 Rest of Europe Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 300 Rest of Europe Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 301 Rest of Europe Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 302 Rest of Europe Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 303 Rest of Europe Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 304 Rest of Europe Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 305 Rest of Europe Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 306 Rest of Europe Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 307 Asia Pacific Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 308 Asia Pacific Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 309 Asia Pacific Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 310 Asia Pacific Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 311 Asia Pacific Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 312 Asia Pacific Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 313 Asia Pacific Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 314 Asia Pacific Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 315 Asia Pacific Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 316 Asia Pacific Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 317 Asia Pacific Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 318 Asia Pacific Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 319 Asia Pacific Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 320 Asia Pacific Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 321 Asia Pacific Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 322 Asia Pacific Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 323 Asia Pacific Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 324 Asia Pacific Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 325 China Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 326 China Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 327 China Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 328 China Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 329 China Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 330 China Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 331 China Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 332 China Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 333 China Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 334 China Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 335 China Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 336 China Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 337 China Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 338 China Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 339 China Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 340 China Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 341 China Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 342 China Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 343 Japan Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 344 Japan Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 345 Japan Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 346 Japan Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 347 Japan Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 348 Japan Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 349 Japan Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 350 Japan Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 351 Japan Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 352 Japan Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 353 Japan Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 354 Japan Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 355 Japan Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 356 Japan Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 357 Japan Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 358 Japan Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 359 Japan Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 360 Japan Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 361 India Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 362 India Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 363 India Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 364 India Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 365 India Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 366 India Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 367 India Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 368 India Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 369 India Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 370 India Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 371 India Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 372 India Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 373 India Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 374 India Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 375 India Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 376 India Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 377 India Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 378 India Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 379 South Korea Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 380 South Korea Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 381 South Korea Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 382 South Korea Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 383 South Korea Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 384 South Korea Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 385 South Korea Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 386 South Korea Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 387 South Korea Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 388 South Korea Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 389 South Korea Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 390 South Korea Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 391 South Korea Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 392 South Korea Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 393 South Korea Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 394 South Korea Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 395 South Korea Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 396 South Korea Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 397 South-East Asia Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 398 South-East Asia Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 399 South-East Asia Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 400 South-East Asia Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 401 South-East Asia Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 402 South-East Asia Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 403 South-East Asia Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 404 South-East Asia Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 405 South-East Asia Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 406 South-East Asia Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 407 South-East Asia Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 408 South-East Asia Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 409 South-East Asia Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 410 South-East Asia Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 411 South-East Asia Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 412 South-East Asia Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 413 South-East Asia Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 414 South-East Asia Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 415 Rest of Asia Pacific Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 416 Rest of Asia Pacific Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 417 Rest of Asia Pacific Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 418 Rest of Asia Pacific Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 419 Rest of Asia Pacific Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 420 Rest of Asia Pacific Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 421 Rest of Asia Pacific Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 422 Rest of Asia Pacific Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 423 Rest of Asia Pacific Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 424 Rest of Asia Pacific Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 425 Rest of Asia Pacific Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 426 Rest of Asia Pacific Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 427 Rest of Asia Pacific Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 428 Rest of Asia Pacific Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 429 Rest of Asia Pacific Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 430 Rest of Asia Pacific Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 431 Rest of Asia Pacific Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 432 Rest of Asia Pacific Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 433 Latin America Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 434 Latin America Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 435 Latin America Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 436 Latin America Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 437 Latin America Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 438 Latin America Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 439 Latin America Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 440 Latin America Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 441 Latin America Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 442 Latin America Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 443 Latin America Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 444 Latin America Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 445 Latin America Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 446 Latin America Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 447 Latin America Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 448 Latin America Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 449 Latin America Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 450 Latin America Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 451 Brazil Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 452 Brazil Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 453 Brazil Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 454 Brazil Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 455 Brazil Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 456 Brazil Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 457 Brazil Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 458 Brazil Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 459 Brazil Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 460 Brazil Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 461 Brazil Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 462 Brazil Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 463 Brazil Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 464 Brazil Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 465 Brazil Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 466 Brazil Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 467 Brazil Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 468 Brazil Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 469 Argentina Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 470 Argentina Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 471 Argentina Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 472 Argentina Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 473 Argentina Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 474 Argentina Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 475 Argentina Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 476 Argentina Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 477 Argentina Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 478 Argentina Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 479 Argentina Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 480 Argentina Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 481 Argentina Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 482 Argentina Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 483 Argentina Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 484 Argentina Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 485 Argentina Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 486 Argentina Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 487 Rest of Latin America Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 488 Rest of Latin America Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 489 Rest of Latin America Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 490 Rest of Latin America Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 491 Rest of Latin America Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 492 Rest of Latin America Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 493 Rest of Latin America Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 494 Rest of Latin America Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 495 Rest of Latin America Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 496 Rest of Latin America Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 497 Rest of Latin America Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 498 Rest of Latin America Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 499 Rest of Latin America Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 500 Rest of Latin America Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 501 Rest of Latin America Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 502 Rest of Latin America Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 503 Rest of Latin America Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 504 Rest of Latin America Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 505 Middle East Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 506 Middle East Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 507 Middle East Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 508 Middle East Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 509 Middle East Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 510 Middle East Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 511 Middle East Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 512 Middle East Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 513 Middle East Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 514 Middle East Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 515 Middle East Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 516 Middle East Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 517 Middle East Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 518 Middle East Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 519 Middle East Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 520 Middle East Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 521 Middle East Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 522 Middle East Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 523 UAE Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 524 UAE Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 525 UAE Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 526 UAE Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 527 UAE Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 528 UAE Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 529 UAE Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 530 UAE Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 531 UAE Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 532 UAE Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 533 UAE Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 534 UAE Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 535 UAE Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 536 UAE Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 537 UAE Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 538 UAE Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 539 UAE Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 540 UAE Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 541 Saudi Arabia Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 542 Saudi Arabia Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 543 Saudi Arabia Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 544 Saudi Arabia Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 545 Saudi Arabia Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 546 Saudi Arabia Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 547 Saudi Arabia Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 548 Saudi Arabia Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 549 Saudi Arabia Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 550 Saudi Arabia Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 551 Saudi Arabia Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 552 Saudi Arabia Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 553 Saudi Arabia Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 554 Saudi Arabia Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 555 Saudi Arabia Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 556 Saudi Arabia Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 557 Saudi Arabia Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 558 Saudi Arabia Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 559 Rest of Middle East Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 560 Rest of Middle East Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 561 Rest of Middle East Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 562 Rest of Middle East Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 563 Rest of Middle East Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 564 Rest of Middle East Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 565 Rest of Middle East Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 566 Rest of Middle East Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 567 Rest of Middle East Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 568 Rest of Middle East Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 569 Rest of Middle East Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 570 Rest of Middle East Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 571 Rest of Middle East Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 572 Rest of Middle East Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 573 Rest of Middle East Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 574 Rest of Middle East Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 575 Rest of Middle East Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 576 Rest of Middle East Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 577 Africa Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 578 Africa Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 579 Africa Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 580 Africa Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 581 Africa Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 582 Africa Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 583 Africa Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 584 Africa Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 585 Africa Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 586 Africa Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 587 Africa Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 588 Africa Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 589 Africa Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 590 Africa Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 591 Africa Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 592 Africa Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 593 Africa Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 594 Africa Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 595 South Africa Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 596 South Africa Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 597 South Africa Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 598 South Africa Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 599 South Africa Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 600 South Africa Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 601 South Africa Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 602 South Africa Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 603 South Africa Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 604 South Africa Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 605 South Africa Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 606 South Africa Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 607 South Africa Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 608 South Africa Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 609 South Africa Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 610 South Africa Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 611 South Africa Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 612 South Africa Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 613 Egypt Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 614 Egypt Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 615 Egypt Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 616 Egypt Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 617 Egypt Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 618 Egypt Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 619 Egypt Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 620 Egypt Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 621 Egypt Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 622 Egypt Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 623 Egypt Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 624 Egypt Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 625 Egypt Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 626 Egypt Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 627 Egypt Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 628 Egypt Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 629 Egypt Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 630 Egypt Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)
TABLE 631 Rest of Africa Drug Discovery Outsourcing Market, by Preclinical Services, 2017-2022 (US$ Mn)
TABLE 632 Rest of Africa Drug Discovery Outsourcing Market, by Preclinical Services, 2023-2030 (US$ Mn)
TABLE 633 Rest of Africa Drug Discovery Outsourcing Market, by Chemistry Services, 2017-2022 (US$ Mn)
TABLE 634 Rest of Africa Drug Discovery Outsourcing Market, by Chemistry Services, 2023-2030 (US$ Mn)
TABLE 635 Rest of Africa Drug Discovery Outsourcing Market, by Biology Services, 2017-2022 (US$ Mn)
TABLE 636 Rest of Africa Drug Discovery Outsourcing Market, by Biology Services, 2023-2030 (US$ Mn)
TABLE 637 Rest of Africa Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 638 Rest of Africa Drug Discovery Outsourcing Market, by Target Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 639 Rest of Africa Drug Discovery Outsourcing Market, by End-User, 2017-2022 (US$ Mn)
TABLE 640 Rest of Africa Drug Discovery Outsourcing Market, by End-User, 2023-2030 (US$ Mn)
TABLE 641 Rest of Africa Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2022 (US$ Mn)
TABLE 642 Rest of Africa Drug Discovery Outsourcing Market, by Therapeutic Area, 2023-2030 (US$ Mn)
TABLE 643 Rest of Africa Drug Discovery Outsourcing Market, by Technology Platforms, 2017-2022 (US$ Mn)
TABLE 644 Rest of Africa Drug Discovery Outsourcing Market, by Technology Platforms, 2023-2030 (US$ Mn)
TABLE 645 Rest of Africa Drug Discovery Outsourcing Market, by Clinical Research Services, 2017-2022 (US$ Mn)
TABLE 646 Rest of Africa Drug Discovery Outsourcing Market, by Clinical Research Services, 2023-2030 (US$ Mn)
TABLE 647 Rest of Africa Drug Discovery Outsourcing Market, by Contract Models, 2017-2022 (US$ Mn)
TABLE 648 Rest of Africa Drug Discovery Outsourcing Market, by Contract Models, 2023-2030 (US$ Mn)

What is the current size of the drug discovery outsourcing market?

The global drug discovery outsourcing market was valued at USD 3748.5 Million in 2022.

What is the expected growth rate of the drug discovery outsourcing market between 2023 and 2030?

The drug discovery outsourcing market is predicted to grow at a CAGR of 8% between 2023 and 2030, reaching USD 6938.2 Million in 2030.

Which category is leading the global market share in terms of preclinical services?

Biochemical assays are the leading preclinical services category, holding over 40% share in value in 2022.

Which chemistry services segment governs the global demand for drug discovery outsourcing?

The medicinal chemistry services segment governs the global demand for drug discovery outsourcing, holding a massive market share of over 55% in 2022.

Which contract models segment will post the highest CAGR in the forecast period?

The functional service outsourcing (FSO) models will post the fastest market CAGR.

Which region is propelling the growth of the drug discovery outsourcing industry?

With more than one-third of the global market share in 2022, North America is driving the industry’s strong expansion in drug discovery outsourcing.

Who are the leading players in the global drug discovery outsourcing market?

The top players include Dalton Pharma Service, Syngene International Ltd, Merck & Co., Dr. Reddy’s Laboratories, Discover X Corporation, Laboratory Corporation of America Holdings, Curia Global Inc., Thermo Fisher Scientific Inc., Charles River Laboratories, TCG Life Science Pvt. Ltd, and Others.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –